<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02156596</url>
  </required_header>
  <id_info>
    <org_study_id>NSAI vs Morphine</org_study_id>
    <nct_id>NCT02156596</nct_id>
  </id_info>
  <brief_title>IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic</brief_title>
  <acronym>NSAIvsNM</acronym>
  <official_title>Intravenous Treatment With Non Steroidal Anti Inflammatory Drugs (NSAID) Versus Nebulized Morphine (NM) Analgesia for First-line Renal Colic: Randomized Controlled Double-blind Single-center Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Monastir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Monastir</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigators study was to evaluate the feasibility, efficacy and safety of
      nebulized morphine compared with non-steroidal anti-inflammatory (NSAI)intravenously in the
      management of renal colic.

      Determine the need for systematic outpatient prescription of NSAI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Renal colic are a frequent cause of consultation in the emergency departement (ED).

      They count for approximatively 20% of patients presenting to the ED with severe acute onset
      abdominal pain.

      For acute treatment of renal colics (RC), guidelines recommend the use of intravenous (IV)
      non-steroidal anti-inflammatory (NSAI) drugs in association with antalgics like Paracetamol
      or Morphine.

      But the NSAID present many inconvenient and cannot be used in some type of patients; that's
      why the investigators investigated the use of other drugs, such as nebulised morphine, in the
      ED treatment of renal colics.

      the NM has the adequacy of being quickest, more practical to use and more tolerated than the
      IV NSAID.

      In this study, the investigators aim to assess the feasibility, efficacity and safety of
      nebulised morphine compared to intravenous NSAID in the treatment of RC.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacity: VAS pain reduction</measure>
    <time_frame>5, 15, 30, 45 and 60 minutes</time_frame>
    <description>The effectiveness of treatment is defined by a decrease in the intensity of pain corresponding to a decrease of the VAS above 50% at 60 minutes compared to baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>feasibility of the study: number of patients accepting the adhesion to protocol</measure>
    <time_frame>at base line and at 60 minutes</time_frame>
    <description>the feasibility is assessed by comparing the number of patients accepting the protocol to the total number of patients consulting for RC; and the number of patients that actually completed the protocol course (if above 50%, the protocol is considered feasable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety: side effects of treatment</measure>
    <time_frame>5, 15, 30, 45 and 60 minutes</time_frame>
    <description>the safety of treatment is evaluated by the occurence of side effects at any time of the protocol.
only major side effects (repeated vomiting, untolerated dizziness, conscience troubles, dyspnea and allergic reaction) are admitted to stop the protocol.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Renal Colic</condition>
  <arm_group>
    <arm_group_label>Intravenous NSAI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients received 100 mg of ketoprofen (NSAID) by IV root and in parallel 3 nebulisation of serum saline (SS) over 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nebulised Morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients received 3 nebulisation of morphine (5 mg each) and in parallel 50 ml of SS by IV root over 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV NSAI</intervention_name>
    <description>100 mg of ketoprofen in 50 ml volume given in 30 minutes by IV root</description>
    <arm_group_label>Intravenous NSAI</arm_group_label>
    <other_name>ketoprofen IV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NM</intervention_name>
    <description>3 nebulisations of 5 mg morphine chlorhydrate each given over 30 minutes (10 minutes per nebulisation)</description>
    <arm_group_label>Nebulised Morphine</arm_group_label>
    <other_name>morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Serum Saline</intervention_name>
    <description>50 ml of SS is given by IV root over 30 minutes</description>
    <arm_group_label>Nebulised Morphine</arm_group_label>
    <other_name>serum saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nebulised Serum Saline</intervention_name>
    <description>3 nebulisations of 5ml SS each are given over 30 minutes</description>
    <arm_group_label>Intravenous NSAI</arm_group_label>
    <other_name>serum saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 16 years old

          -  Consenting to participate in the study

          -  Diagnosis of renal colic matching flank pain / lumbar fossa sided with dipstick and /
             or imaging confirmed the diagnosis

          -  VAS&gt; 50% at consultation

        Exclusion Criteria:

          -  Inability to assess pain VAS;

          -  Pregnant or lactating woman;

          -  Recognized renal disease (glomerular filtration rate &lt;60ml/kg/1.73m2);

          -  Known hepatic insufficiency;

          -  Known or suspected allergy to NSAIDs, morphine

          -  Peptic ulcer known;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nouira Semir, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Monastir</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of Fattouma Bourguiba</name>
      <address>
        <city>Monastir</city>
        <zip>5000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <link>
    <url>http://www.urgencemonastir.com</url>
    <description>official department site</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 3, 2014</study_first_submitted>
  <study_first_submitted_qc>June 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2014</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Monastir</investigator_affiliation>
    <investigator_full_name>Pr. Semir Nouira</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>renal colic</keyword>
  <keyword>nebulised morphine</keyword>
  <keyword>Intravenous NSAID</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

